Holen Sie sich die Stockscreener-App
137.34
0.09%
0.13
Handel nachbörslich:
137.20
-0.14
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GILD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten
Gilead Sciences (GILD) Nears $2 Billion Acquisition of Ouro Medi - GuruFocus
Gilead (GILD) Edges Toward $2 Billion Acquisition of Ouro Medici - GuruFocus
Gilead nearing up to $2 billion buyout of biotech Ouro Medicines, FT reports By Reuters - Investing.com
Gilead Sciences nears $2 billion Ouro Medicines acquisition - Investing.com Australia
Gilead boss' compensation jumped 20% last year to $28.4 million - The Business Journals
Weekly Recap: Should I set a stop loss on Gilead Sciences Inc2026 WrapUp & Verified Entry Point Signals - baoquankhu1.vn
Gilead Sciences to Buy Arcellx in $7.8B Deal to Strengthen Cell Therapy Portfolio - The Healthcare Technology Report.
Stock Recap: What is the next catalyst for Gilead Sciences Inc2026 Trade Ideas & Weekly Consistent Profit Watchlists - baoquankhu1.vn
GILD.SW Gilead Sciences SIX up 70.33% pre-market 23 Mar 2026: valuation risk - Meyka
Arcellx earnings on deck ahead of Gilead acquisition close - Investing.com
Nordea Investment Management AB Increases Position in Gilead Sciences, Inc. $GILD - MarketBeat
New England Research & Management Inc. Buys New Stake in Gilead Sciences, Inc. $GILD - MarketBeat
IAM Advisory LLC Takes $1.27 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
BCGM Wealth Management LLC Invests in Gilead Sciences - National Today
BCGM Wealth Management LLC Makes New Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Here is what to know beyond why Gilead Sciences, Inc. (GILD) is a trending stock - MSN
Former Gilead Sciences GC To Earn Over $2.5M Severance - Law360
Gilead Sciences Inc. stock underperforms Friday when compared to competitors - MarketWatch
Gilead Ends Obeldesivir Filovirus Prophylaxis Trial: What It Means for GILD Investors - TipRanks
Gilead could potentially end HIV. But will it be able to? - Pharma Voice
Groupama Asset Managment Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Confluence Investment Management LLC Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Anderson Hoagland & Co. Purchases New Stake in Gilead Sciences, Inc. $GILD - MarketBeat
AIA Group Ltd Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - Yahoo Finance
CIBC Bancorp USA Inc. Invests $24.42 Million in Gilead Sciences - National Today
Gilead Sciences, Inc. $GILD Shares Bought by Swiss Life Asset Management Ltd - MarketBeat
Investment Research Partners LLC Takes $928,000 Position in Gilead Sciences, Inc. $GILD - MarketBeat
CIBC Bancorp USA Inc. Makes New $24.42 Million Investment in Gilead Sciences, Inc. $GILD - MarketBeat
Coldstream Capital Management Inc. Acquires 8,807 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
A Look At Gilead Sciences (GILD) Valuation As Recent Returns Send Mixed Signals - Yahoo Finance
Gilead Sciences (GILD) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance Australia
Gilead Sciences Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Ciara Is Bringing Back the Pop Culture PSA (Exclusive) - Cosmopolitan
Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN
Gilead Sciences initiates challenging study for aggressive breast cancer form - Traders Union
Antiretroviral Therapy Market Critical Analysis with Expert Opinion| Gilead Sciences, Viatris, AbbVie - openPR.com
Gilead Sciences Inc Stock (GILD) Moved Down by 3.37% on Mar 18: Facts Behind the Movement - TradingKey
Gilead Sciences Stock Performance vs. Business Health Analysis 2026News and Statistics - IndexBox
Is trending stock Gilead Sciences, Inc. (GILD) a buy now? - MSN
Danske Bank A S Takes $133.05 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Captrust Financial Advisors Has $211.80 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Achmea Investment Management B.V. - MarketBeat
Gilead Sciences CFO Dickinson sells $432k in stock - Investing.com
Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares - MarketBeat
Insider Sell: Andrew Dickinson Sells Shares of Gilead Sciences I - GuruFocus
Gilead (GILD) executive sells 3,000 shares in planned trade - Stock Titan
Gilead Sciences (NASDAQ:GILD) CFO Sells $432,690.00 in Stock - MarketBeat
Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer - Femtech Insider
Gilead Sciences ASCENT-04 regimen gains Category 1 status in updated NCCN guidelines - Traders Union
Manta Cares and Gilead Sciences Collaborate to Support Patients Navigating Metastatic Lung and Breast Cancer - PRWeb
Cantor Fitzgerald reiterates Gilead stock rating on Yeztugo sales - Investing.com
National Bank of Canada FI Has $161.14 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Conference: 6-Month HIV Regimens, 12-Month PrEP, Livdelzi Expansion, Oncology Push - Yahoo Finance
Gilead Sciences at Barclays: CFO touts YEZTUGO launch, Arcellx deal and “long cycle” growth - MarketBeat
Fort Point Capital Partners LLC Sells 8,153 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Bank of Nova Scotia Reduces Gilead Sciences Stake - National Today
CSM Advisors LLC Sells 42,400 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Bank of Nova Scotia Sells 319,843 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal - The Motley Fool
Johanna Mercier sells 28,000 shares at GILD (NASDAQ: GILD) — Form 144 notice - Stock Titan
Gotham Asset Management Increases Gilead Sciences Stake - National Today
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Down 15.7% in February - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Holocene Advisors LP - MarketBeat
Gotham Asset Management LLC Has $38.40 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Crawford Investment Counsel Inc. Decreases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (GILD): Growth prospects backed by analyst upgrades - MSN
Gilead Sciences, Inc. (GILD): Growth Prospects Backed by Analyst Upgrades - Insider Monkey
Capitolis Liquid Global Markets LLC Invests $40.40 Million in Gilead Sciences, Inc. $GILD - MarketBeat
Calydon Capital Has $7.34 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Chevy Chase Trust Holdings LLC Has $70.93 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
California Public Employees Retirement System Has $447.80 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
BNP Paribas Has $7.71 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Grows Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
0.79%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):